These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3895923)

  • 21. Empiric treatment of infections in neutropenic patients with cancer.
    Klastersky J
    Rev Infect Dis; 1983; 5 Suppl 1():S21-31. PubMed ID: 6342096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M. D. Anderson Hospital.
    Bodey GP
    Rev Infect Dis; 1989; 11 Suppl 7():S1582-90. PubMed ID: 2690296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of bacterial infections in severely neutropenic subjects.
    Vincent PC; Fabre S; Jennis F
    Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):30-3. PubMed ID: 244772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
    Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
    Marie JP; Pico JL; Chiche D; Fitoussi F; Delmer A; Baume D; Rio B; Ajchenbaum F; Richet H; Tancrède C
    Presse Med; 1988 Oct; 17(37):1968-70. PubMed ID: 2973598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of amikacin usage in the EORTC trials.
    Zinner SH
    Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The febrile neutropenic patient: newer options for empirical therapy.
    Rubin M; Walsh T; Butler K; Lee J; Lecciones J; Weinberger M; Roilides E; Gress J; Marshall D; Pizzo PA
    Haematol Blood Transfus; 1990; 33():531-8. PubMed ID: 2157645
    [No Abstract]   [Full Text] [Related]  

  • 30. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.
    Hathorn JW; Rubin M; Pizzo PA
    Antimicrob Agents Chemother; 1987 Jul; 31(7):971-7. PubMed ID: 3310871
    [No Abstract]   [Full Text] [Related]  

  • 31. The management of febrile episodes in-neutropenic cancer.
    Bishop JF; McLennan R; Whiteside MG
    Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
    Baruchel A; Hartmann O; Andremont A; Tancrède C
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aztreonam therapy in neutropenic patients with cancer.
    Jones PG; Rolston KV; Fainstein V; Elting L; Walters RS; Bodey GP
    Am J Med; 1986 Aug; 81(2):243-8. PubMed ID: 3526885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of infection in granulopenic patients. Lessons from international studies].
    Beytout J; Travade P; Petit MF
    Presse Med; 1988 Oct; 17(37):1950-3. PubMed ID: 2973594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease.
    Tattersall MH; Hutchinson RM; Gaya H; Spiers AS
    Eur J Cancer (1965); 1973 Jun; 9(6):417-23. PubMed ID: 4372049
    [No Abstract]   [Full Text] [Related]  

  • 36. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
    Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ceftazidime for the treatment of infections in neutropenic children].
    Leverger G; Arlet G; Bancillon A; Schaison G
    Presse Med; 1988 Oct; 17(37):1974-6. PubMed ID: 2973600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
    Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
    Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
    Zinner SH
    Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.